Home
>
National Drug Code (NDC)
>
Lorzone
Lorzone - 68025-046-02 - (chlorzoxazone)
Drug Information of Lorzone
| Product NDC: | 68025-046 |
| Proprietary Name: | Lorzone |
| Non Proprietary Name: | chlorzoxazone |
| Active Ingredient(s): | 375 mg/1 & nbsp; chlorzoxazone |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Lorzone
| Product NDC: | 68025-046 |
| Labeler Name: | Vertical Pharmaceuticals, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA040861 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20111001 |
Package Information of Lorzone
| Package NDC: | 68025-046-02 |
| Package Description: | 2 POUCH in 1 BOX, UNIT-DOSE (68025-046-02) > 1 TABLET in 1 POUCH (68025-046-01) |
NDC Information of Lorzone
| NDC Code | 68025-046-02 |
| Proprietary Name | Lorzone |
| Package Description | 2 POUCH in 1 BOX, UNIT-DOSE (68025-046-02) > 1 TABLET in 1 POUCH (68025-046-01) |
| Product NDC | 68025-046 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | chlorzoxazone |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20111001 |
| Marketing Category Name | ANDA |
| Labeler Name | Vertical Pharmaceuticals, Inc. |
| Substance Name | CHLORZOXAZONE |
| Strength Number | 375 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Centrally-mediated Muscle Relaxation [PE],Muscle Relaxant [EPC] |
